Model Building Strategy
A Model Building Strategy is a systematic methodological framework that specifies the sequence and criteria for selecting, evaluating, and refining structural and statistical components in the development of population pharmacokinetic models.
266
Publications
21.1K
Citations
1.1K
Authors
502
Institutions
Publications per year
2017–2026
81
266
tRNAscan-SE 2.0: improved detection and functional classification of transfer RNA genes
Patricia P. Chan, Brian Y Lin, Allysia J. Mak et al. · Nucleic Acids Research · 2021 · 1.9K citations · Full text
Logistic Regression: A Brief Primer
Jill Stoltzfus · Academic Emergency Medicine · 2011 · 1.3K citations
1–5 of 266
1.1K
4
h-index
4
h-index
3
h-index
3
h-index
Indian Institute of Technology Kharagpur, India
3 publications · 171 citations
3
h-index
1–5 of 1.1K
502
Pfizer (United States)
New York, United States
9 h-index
27 publications
2K citations
Carnegie Mellon University
Pittsburgh, United States
7 h-index
10 publications
352 citations
Inserm
Paris, France
6 h-index
16 publications
351 citations
Bristol-Myers Squibb (United States)
New York, United States
6 h-index
18 publications
1.2K citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
5 h-index
13 publications
424 citations

Uppsala University
Uppsala, Sweden
5 h-index
13 publications
2.9K citations
Center for Drug Evaluation and Research
Silver Spring, United States
5 h-index
30 publications
1.6K citations
University of Wisconsin–Madison
Madison, United States
5 h-index
7 publications
171 citations
1–8 of 502
PSP · 15 publications · 1.4K citations
14
h-index
8 publications · 254 citations
8
h-index
BJCP · 5 publications · 305 citations
5
h-index
5 publications · 221 citations
5
h-index
5 publications · 404 citations
5
h-index
1–5